Cargando…
CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma
Gastric cardia adenocarcinoma (GCA) is the most aggressive subtype of gastric cancer with a high metastatic rate. In this report, we collected tumor tissue samples from 214 GCA cases and examined expression of CYR61, a target gene product of the Hippo-YAP/TAZ pathway, in the GCA tumors by immunohist...
Autores principales: | Wei, Jing, Yu, Guanzhen, Shao, Genbao, Sun, Aiqin, Chen, Miao, Yang, Wannian, Lin, Qiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058739/ https://www.ncbi.nlm.nih.gov/pubmed/27105510 http://dx.doi.org/10.18632/oncotarget.8845 |
Ejemplares similares
-
The Hippo signaling effector WWTR1 is a metastatic biomarker of gastric cardia adenocarcinoma
por: Wei, Jing, et al.
Publicado: (2019) -
Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis
por: Sun, Aiqin, et al.
Publicado: (2014) -
The Roles of CCN1/CYR61 in Pulmonary Diseases
por: Zhu, Yin, et al.
Publicado: (2020) -
Cyr61/CCN1 targets for chemosensitization in pancreatic cancer
por: Banerjee, Snigdha, et al.
Publicado: (2019) -
The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts
por: Todorovicç, Viktor, et al.
Publicado: (2005)